Johnson & Johnson Challenges the Constitutionality of FCA $1.6 Billion Verdict -
Following a record $1.6 billion jury verdict for off-label promotion of HIV drugs Prezista and Intelence, Johnson & Johnson (J&J) subsidiary...more
7/28/2025
/ Anti-Kickback Statute ,
Appeals ,
CARES Act ,
Constitutional Challenges ,
Coronavirus/COVID-19 ,
Department of Justice (DOJ) ,
Economic Injury Disaster Loans ,
False Claims Act (FCA) ,
First Amendment ,
Jury Verdicts ,
Paycheck Protection Program (PPP) ,
Penalties ,
Pharmaceutical Industry ,
Prescription Drugs ,
Scienter ,
Tax Fraud ,
Whistleblowers